Properties (58)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Actavis_UK_in_2016
|
| gptkbp:awards |
Excellence in Healthcare Award
Innovation in Pharma Award Best_Pharmaceutical_Company_Award |
| gptkbp:businessModel |
Vertical integration
Focus on specialty pharmaceuticals Focus on biosimilars Focus on generics |
| gptkbp:clinicalTrials |
Conducts clinical trials globally
|
| gptkbp:community_engagement |
Health camps
Support for local communities Awareness programs |
| gptkbp:employees |
Over 10,000
|
| gptkbp:exportedTo |
Over 70 countries
|
| gptkbp:founded |
1984
|
| gptkbp:founder |
gptkb:Bhavin_S._Patel
|
| gptkbp:governance |
Ethical business practices
Transparency in operations Strong corporate governance practices |
| gptkbp:headquarters |
Ahmedabad,_India
|
| https://www.w3.org/2000/01/rdf-schema#label |
Intas Pharma Ltd.
|
| gptkbp:investmentFocus |
Increased investment in R&D
New product development Expansion of manufacturing capacity |
| gptkbp:market |
Global
Growing presence in international markets Significant_market_share_in_India |
| gptkbp:partnerships |
Research institutions
Local distributors Various global pharmaceutical companies Healthcare_providers |
| gptkbp:productionLocation |
Multiple_locations_in_India
|
| gptkbp:products |
Biopharmaceuticals
Over-the-counter drugs Generic_pharmaceuticals |
| gptkbp:regulatoryCompliance |
WHO prequalified
FDA_approved EMA_approved |
| gptkbp:research_areas |
gptkb:India
gptkb:United_States Cardiology Europe Gastroenterology Oncology Pain management Urology Diabetes Neurology Infectious diseases Dermatology Respiratory |
| gptkbp:revenue |
$1 billion (2020)
|
| gptkbp:social_responsibility |
Education initiatives
Environmental sustainability initiatives Healthcare_initiatives |
| gptkbp:subsidiary |
gptkb:Intas_Pharmaceuticals_Ltd.
|
| gptkbp:website |
www.intaspharma.com
|